How much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?

Scandinavian Journal of Rheumatology

Volumn 40, Issue SUPPL. 125, 2011, Pages 12-16

  Tuominen, Risto ^a   Tuominen, S ^b   Moottoonen T ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC ASPECT; EMOTION; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYMPTOM; TREATMENT DURATION; AGED; CIRCADIAN RHYTHM; COMPARATIVE STUDY; COST OF ILLNESS; ECONOMICS; HOSPITALIZATION; INTERVIEW; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; SICKNESS IMPACT PROFILE;

AGED; ARTHRITIS, RHEUMATOID; CIRCADIAN RHYTHM; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 79955602647     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2011.566435     Document Type: Article

References (18)

1. Lundkvist J, Kastang F, Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 2008;8:S49-60.
2. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-83. (Pubitemid 44277392)
3. Ruof J, Hulsemann J, Mittendorf T, Handelmann S, von der Scholenburg J, Zeidler H, et al. Cost of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 2003;62:544-50. (Pubitemid 36606288)
4. Kobelt G. Thoughts on health economics in rheumatoid arthritis. Ann Rheum Dis 2007;66:iii35-9.
5. Westhoff G, Butthereit F, Gromnica-Ihle E, Zink A. Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatology 2008;47:980-4. (Pubitemid 351865919)
6. Reisine S, Fifield J, Walsh S, Dauser D. Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis. Arthritis Rheum 2007;57:372-80. (Pubitemid 46682523)
7. de Croon EM, Sluiter J, Nijssen T, Dijkmans B, Lankhorst G, Frings-Dresen M. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2004;63:1362-7. (Pubitemid 39433936)
8. Hazes J, Hayton R, Burt J, Silman A. Consistency of morning stiffness: an analysis of diary data. Br J Rheumatol 1994; 33:562-5. (Pubitemid 24179261)
9. Kobelt G, Jonsson B. The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatment. Eur J Health Econ 2008;8(Suppl 2):95-106.
10. Torrance G. Measurement of health state utilities for economic appraisal. A review. J Health Econ 1986;5:1-30. (Pubitemid 16098443)
11. Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, et al. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making 2007;27:138-50. (Pubitemid 46568906)
12. Slothuus U, Brooks R. Willingness to pay in arthritis: a Danish contribution. Rheumatology 2000;39:791-9. (Pubitemid 30487903)
13. Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, et al. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective. J Rheumatol 2005;32:443-53. (Pubitemid 40381414)
14. Tuominen R, Azbel M, Hemmila J, Mottonen T. Willingness to pay for improvement of physical function among rheumatoid arthritis patients as measured by Health Assessment Questionnaire. Rheumatol Int 2011;31:347-52.
15. Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Julkunen H, et al. Impact of initial aggressive drug treatment with combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a fiveyear randomized follow-up trial. Arthritis Rheum 2004;50:55-62. (Pubitemid 38084287)
16. Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52:36-41. (Pubitemid 40129230)
17. Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 2007;56:399-408.
18. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): double-blind, randomized controlled trial. Lancet 2008;371:205-14.